[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.161.241.199. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
June 1983

Pyoderma GangrenosumResponse to Cyclophosphamide Therapy

Author Affiliations

From the Department of Dermatology, Rush-Presbyterian—St Luke's Medical Center, Chicago.

Arch Dermatol. 1983;119(6):495-497. doi:10.1001/archderm.1983.01650300049015
Abstract

• A 46-year-old woman had a 17-year history of intermittently severe pyoderma gangrenosum without identifiable associated systemic disease. Her condition had become unresponsive to corticosteroid and sulfone therapy given for systemic effect, but responded completely to 150 mg/day of cyclophosphamide. Immunosuppressive therapy should be considered in patients with severe, recalcitrant pyoderma gangrenosum, even in the absence of associated systemic disease.

(Arch Dermatol 1983;119:495-497)

×